OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of the American Heart Association is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
AhR, IRF5, and HO‐1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study	208
Level of Perivascular Inflammation Is Significantly Lower Around the Left Internal Mammary Artery Than Around Native Coronary Arteries	191
Diabetes Enters Stage Right: Genetic Association Studies Suggest Diabetes Promotes Pulmonary Hypertension and Right Ventricular Dysfunction	176
Understanding Participant Perspectives Toward the Formation of a Participant Advisory Board Within the Reasons for Geographic and Racial Differences in Stroke Study: A National Qualitative Study	173
Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS	169
Challenges in Assessing Stroke Incidence in Low‐ and Middle‐Income Countries	167
Do Individuals With Inherited Cardiac Diseases Experience Reproductive Decision‐Making Guilt?	153
CanCHD Study of Hematopoietic Cancers in Children With and Without Genetic Syndromes	148
Reduced Capacity of High‐Density Lipoprotein to Acquire Free Cholesterol From Triglyceride‐Rich Lipoproteins Is Associated With Elevated Postprandial Hypertriglyceridemia in Healthy Men	144
Clinical Metabolomic Landscape of Cardiovascular Physiology and Disease	136
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy	133
Editors and Editorial Board	131
Association of Hypertension With Early‐Onset Cryptogenic Ischemic Stroke by the Presence of Patent Foramen Ovale: A Case–Control Study	126
Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes t	122
Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease	122
Ultrafast Cooling With Total Liquid Ventilation Mitigates Early Inflammatory Response and Offers Neuroprotection in a Porcine Model of Cardiac Arrest	118
Bench to all Bedsides in Genomics and Precision Medicine	114
Left Ventricular Outflow Tract Morphology as a Predictor of Conductance Disturbances Following Transcatheter Aortic Valve Replacement	106
Cardiovascular Complications With Delivery Hospitalizations in Patients With Pulmonary Hypertension: A Nationwide Study From 2011 to 2020	105
Inpatient‐Onset Versus Outpatient‐Onset ST‐Segment–Elevation Myocardial Infarction in Patients With Percutaneous Coronary Intervention: A National Registry Study	105
Multi‐Trait Polygenic Risk Score, Nongenetic Determinants, and Cardiovascular Disease Death: A Cohort Study of 14 086 Japanese Individuals	103
Comparison of Centers for Disease Control and Prevention and Hospital‐Based Stroke Mortality Data in Kentucky: The Paul Coverdell National Acute Stroke Program	103
Discrimination Between Pre‐ and Postcapillary Pulmonary Hypertension Using Platelet RNA	101
Myocardial Infarction Across COVID‐19 Pandemic Phases: Insights From the Veterans Health Affairs System	101
Number of Live Births as a Protective Factor Against Clinical and Covert Brain Infarcts: The Framingham Heart Study	100

Contributions of Women to Cardiovascular Science Over Two Decades: Authorship, Leadership, and Mentorship	99
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold‐Standard Clinical Models in Multiethnic Populations	97
Proton Pump Inhibitor Use and Incident Hypertension in Menopausal Women	95
Racial and Ethnic Disparities in the Medical Management of Poststroke Complications Among Patients With Acute Stroke	89
Association Between Maternal Factors in Early Pregnancy and Congenital Heart Defects in Offspring: The Japan Environment and Children's Study	83
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?	81
Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression	78
Contributions of Germline and Somatic Mosaic Genetics to Thoracic Aortic Aneurysms in Nonsyndromic Individuals	76
Correction to: Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease	75
Correction to: Racial and Ethnic Differences in the Association between Classical Cardiovascular Risk Factors and Common Carotid Intima‐Media Thickness: An Individual Participant Data Meta‐Analysis	75
Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results	73
Relationship Between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease	72
Correction to: Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway	72
Correction to: Comparison of Effectiveness Among Different Sodium‐Glucose Cotransporter‐2 Inhibitors According to Underlying Conditions: A Network Meta‐Analysis of Randomized Controlled Trials	71
Saliva, Plasma, and Multifluid Metabolomic Signatures of Periodontal Disease, Type 2 Diabetes Progression, and Markers of Glycemia and Dyslipidemia Among Puerto Rican Adults With Overweight and Obesit	71
Positive Predictive Value of International Classification of Diseases, Ninth Revision, Clinical Modification , and International Classification of Disease	70
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure	67
Independent and Incremental Value of ECG Markers for Prediction of Cancer Therapy‐Related Cardiac Dysfunction	66
Cardiovascular Health Metrics Differ Between Individuals With and Without Cancer	66
Co‐Occurrence of Social Risk Factors and Associated Outcomes in Patients With Heart Failure	65
Randomized, Placebo‐Controlled, Triple‐Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline‐Based Cancer Therapy	65
Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS	65
Day‐to‐Day Blood Pressure Variability and Risk of Incident Chronic Kidney Disease in a General Japanese Population	64
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance	64
Real‐Time Ambulatory ECG Does Not Expedite Care	64
Novel Size‐Based High‐Density Lipoprotein Subspecies and Incident Vascular Events	63
Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention	62
Postnatal Deletion of Bmal1 in Cardiomyocyte Promotes Pressure Overload Induced Cardiac Remodeling in Mice	62
Defining Spiritual Wellbeing in Survivors of Stroke: A Convergent Parallel Mixed Methods Study	61
Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium	61
Protective Effect on Spinal Cord Injury of Prophylactic Cerebrospinal Fluid Drainage in Extensive Aortic Arch Repair for Type A Aortic Dissection: A Retrospective Cohort Study	61
Lipid‐Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials	60
Heart Failure–Related Death in Subjects With Atrial Fibrillation in the United States, 1999 to 2020	60
Survival Benefit of Heart–Kidney Versus Heart Transplant With or Without Delayed Kidney Transplant	60
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score	60